SIMPLEX TRADING, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$221,000
-40.4%
3,250
-69.7%
0.00%
Q1 2022$371,000
-69.8%
10,714
-67.4%
0.00%
-100.0%
Q3 2021$1,228,000
+14.2%
32,897
+7.2%
0.00%0.0%
Q2 2021$1,075,000
+189.8%
30,697
+236.5%
0.00%0.0%
Q1 2021$371,000
-85.3%
9,123
-84.3%
0.00%
-66.7%
Q4 2020$2,523,000
+2152.7%
58,260
+2554.2%
0.00%
Q1 2020$112,000
-87.8%
2,195
-87.4%
0.00%
-100.0%
Q2 2019$918,000
+134.8%
17,467
+135.9%
0.00%
+200.0%
Q1 2019$391,000
-26.6%
7,405
-43.1%
0.00%
-50.0%
Q4 2018$533,000
+40.3%
13,004
+29.8%
0.00%
+100.0%
Q3 2018$380,000
-42.2%
10,018
-26.5%
0.00%
-96.6%
Q1 2018$658,000
+647.7%
13,635
+321.0%
0.03%
+625.0%
Q2 2017$88,000
+49.2%
3,239
-21.6%
0.00%0.0%
Q4 2016$59,000
-40.4%
4,131
-30.9%
0.00%
-42.9%
Q2 2016$99,000
+73.7%
5,974
+63.9%
0.01%
+40.0%
Q1 2016$57,0003,6440.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders